146 related articles for article (PubMed ID: 3073285)
1. The influence of antimycobacterial chemotherapy on delayed hypersensitivity skin-test reactions in leprosy patients.
Cree IA; Smith WC; Rees RJ; Beck JS
Lepr Rev; 1988 Jun; 59(2):145-51. PubMed ID: 3073285
[No Abstract] [Full Text] [Related]
2. Antigens of Mycobacterium leprae in urine during treatment of patients with lepromatous leprosy.
Olcén P; Harboe M; Warndorff van Diepen T
Lepr Rev; 1986 Dec; 57(4):329-40. PubMed ID: 3540495
[No Abstract] [Full Text] [Related]
3. Etiological factors in delayed-type hypersensitivity reactions in leprosy.
Klenerman P
Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):702-12. PubMed ID: 3123582
[No Abstract] [Full Text] [Related]
4. Failure to induce delayed-type hypersensitivity to Mycobacterium leprae in long-term treated lepromatous leprosy patients.
Smelt AH; Rees RH; Liew FY
Clin Exp Immunol; 1981 Jun; 44(3):507-11. PubMed ID: 7035031
[TBL] [Abstract][Full Text] [Related]
5. Suppression of delayed hypersensitivity skin reactions to tuberculin by M. leprae antigens in patients with lepromatous and tuberculoid leprosy.
Sengupta U; Sinha S; Ramu G; Lamb J; Ivanyi J
Clin Exp Immunol; 1987 Apr; 68(1):58-64. PubMed ID: 3308210
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and treatment of leprosy type 1 (reversal) reaction.
Sung SM; Kobayashi TT
Cutis; 2015 Apr; 95(4):222-6. PubMed ID: 25942024
[TBL] [Abstract][Full Text] [Related]
7. The effects of chemotherapy on antibody levels in lepromatous patients.
Douglas JT; Steven LM; Fajardo T; Cellona RV; Madarang MG; Abalos RM; Steenbergen GJ
Lepr Rev; 1988 Jun; 59(2):127-35. PubMed ID: 3073284
[No Abstract] [Full Text] [Related]
8. Changes in cellular response to mycobacterial antigens and cytokine production patterns in leprosy patients during multiple drug therapy.
Trao VT; Huong PL; Thuan AT; Anh DD; Trach DD; Rook GA; Wright EP
Immunology; 1998 Jun; 94(2):197-206. PubMed ID: 9741341
[TBL] [Abstract][Full Text] [Related]
9. The response to chemotherapy of serum Mycobacterium leprae-specific antigen in multibacillary leprosy patients.
Roche PW; Britton WJ; Neupane KD; Failbus SS; Cho SN; Theuvenet WJ
Am J Trop Med Hyg; 1991 Jun; 44(6):702-8. PubMed ID: 1858971
[TBL] [Abstract][Full Text] [Related]
10. Delayed-type hypersensitivity to Mycobacterium leprae soluble antigens as a test for infection with the leprosy bacillus.
Sterne JA; Fine PE; Pönnighaus JM; Rees RJ; Chavula D
Int J Epidemiol; 1998 Aug; 27(4):713-21. PubMed ID: 9758130
[TBL] [Abstract][Full Text] [Related]
11. Use of soluble antigens in leprosy epidemiology.
Gupte MD; Anantharaman DS
Lepr Rev; 1988 Dec; 59(4):329-35. PubMed ID: 3072456
[No Abstract] [Full Text] [Related]
12. A longitudinal study of immunologic reactivity in leprosy patients treated with immunotherapy.
Rada E; Ulrich M; Aranzazu N; Santaella C; Gallinoto M; Centeno M; Rodriguez V; Convit J
Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):552-8. PubMed ID: 7868953
[TBL] [Abstract][Full Text] [Related]
13. Failure of Mycobacterium leprae soluble antigens to suppress delayed-type hypersensitivity reaction to tuberculin.
Fine PE; Gruer PJ; Maine N; Ponnighaus JM; Rees RJ; Stanford JL
Clin Exp Immunol; 1989 Aug; 77(2):226-9. PubMed ID: 2673590
[TBL] [Abstract][Full Text] [Related]
14. [Diagnosis and treatment of leprosy].
López-Antuñano FJ
Salud Publica Mex; 1998; 40(1):66-75. PubMed ID: 9580503
[No Abstract] [Full Text] [Related]
15. A review of immunopathologic studies of human leprosy lesions in situ.
Scollard DM
Hawaii Med J; 1988 Feb; 47(2):54-8. PubMed ID: 3284839
[No Abstract] [Full Text] [Related]
16. Delayed hypersensitivity skin reactions to lepromin and antigens prepared from four other mycobacteria.
Govil DC; Bhutani LK
Lepr India; 1978 Oct; 50(4):550-4. PubMed ID: 374872
[No Abstract] [Full Text] [Related]
17. Monitoring the effects of preventive therapy in the Federated States of Micronesia.
Cho SN; Walsh GP; Brennan PJ
Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4 Suppl):S19-22. PubMed ID: 10700932
[No Abstract] [Full Text] [Related]
18. Association between leprosy reactions after treatment and bacterial load evaluated using anti PGL-I serology and bacilloscopy.
Brito Mde F; Ximenes RA; Gallo ME; Bührer-Sékula S
Rev Soc Bras Med Trop; 2008; 41 Suppl 2():67-72. PubMed ID: 19618079
[TBL] [Abstract][Full Text] [Related]
19. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
[TBL] [Abstract][Full Text] [Related]
20. Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity.
Fine PE; Sterne JA; Pönnighaus JM; Rees RJ
Lancet; 1994 Nov; 344(8932):1245-9. PubMed ID: 7967984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
